Choosing Wisely in hemato-medical oncology
Choosing Wisely in hemato-medical oncology
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Precision oncology: Present and future in breast cancer
CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG
Advancing breast cancer diagnosis in the developing world
Choosing wisely in multiple myeloma
Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC
Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery
Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable intermediate to very high-risk prostate cancer
Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity
Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men
Single intensive screening intervention using PSA and Stockholm3 in combination might reduce prostate cancer mortality